他汀治疗对基线低密度脂蛋白胆固醇偏低卒中患者心血管结局的影响
本研究基于2011至2020年一项持续进行的卒中登记,筛选基线低密度脂蛋白胆固醇(LDL-C)低于推荐目标且卒中前未使用他汀的缺血性卒中患者,采用稳定化逆概率治疗加权Cox回归分析,发现卒中后他汀治疗与1年随访期间主要血管事件风险降低相关(加权HR 0.55,95%CI 0.42-0.71)。
要点
- 基线LDL-C低于目标的他汀初治卒中患者,卒中后他汀治疗与主要血管事件风险降低相关(加权HR 0.55)。
- 在LDL-C极低(<55 mg/dL)或<70 mg/dL亚组中,他汀治疗亦与主要血管事件减少相关(加权HR 0.45)。
- 获益最大的他汀强度因卒中亚型而异。
核心结论
- 他汀治疗可能改善缺血性卒中后的血管结局,即使LDL-C低于目标且卒中前未接受降脂治疗。
研究设计与样本
- 研究基于一项持续进行的卒中登记,筛选2011至2020年间发生缺血性卒中、基线LDL-C低于推荐目标(动脉粥样硬化性卒中≤70 mg/dL,非动脉粥样硬化性卒中≤100 mg/dL)且卒中前未使用他汀的患者。
- 共纳入1,858例患者(平均年龄67.9±15.3岁,男性61.4%,动脉粥样硬化性卒中13.2%),基线LDL-C为75.7±17.0 mg/dL。
- 采用稳定化逆概率治疗加权Cox回归分析,评估卒中后他汀治疗对主要血管事件(复发性卒中、心肌梗死和死亡的复合终点)的影响。
主要发现
- 1,256例(67.7%)患者接受他汀处方(低至中等强度23.5%,高强度44.1%)。
- 卒中后他汀治疗与1年随访期间主要血管事件风险降低相关(加权HR 0.55,95%CI 0.42-0.71)。
- 在动脉粥样硬化性心血管疾病极高风险且LDL-C<55 mg/dL或非极高风险且LDL-C<70 mg/dL的亚组中,卒中后他汀治疗亦与主要血管事件减少相关(加权HR 0.45,95%CI 0.29-0.70)。
- 获益最大的他汀强度因卒中亚型而异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether post-stroke statin therapy reduces subsequent major vascular events in statin-naïve patients with pretreatment low-density lipoprotein cholesterol (LDL-C) below the recommended target (≤70 mg/dL for atherosclerotic stroke and ≤100 mg/dL for non-atherosclerotic stroke) at stroke onset. METHODS: Patients from an ongoing stroke registry who had an ischemic stroke between 2011 and 2020 were screened. Statin naïve patients with baseline LDL-C below the target were assessed. The effect of post-stroke statin therapy on major vascular events (composite of recurrent stroke, myocardial infarction, and death) was investigated using weighted Cox regression analyses using stabilized inverse probability treatment weighting. RESULTS: The baseline LDL-C level of the 1,858 patients (mean age 67.9 ± 15.3 years, 61.4% men, 13.2% atherosclerotic stroke) included in the study was 75.7 ± 17.0 mg/dL. Statins were prescribed to 1,256 (67.7%) patients (low-to-moderate intensity, 23.5%; high intensity, 44.1%). Post-stroke statin therapy was associated with a lower risk of major vascular events during 1-year follow-up (weighted hazard ratio 0.55, 95% confidence interval 0.42-0.71). In a subgroup of patients who were at very high risk of atherosclerotic cardiovascular disease with LDL-C <55 mg/dL or patients who were not at very high risk of atherosclerotic cardiovascular disease with LDL-C <70 mg/dL, post-stroke statin therapy was also associated with a reduction in major vascular events (weighted hazard ratio 0.45, 95% confidence interval 0.29-0.70). The intensity of the most beneficial statin varied by subtype of stroke. INTERPRETATION: Statin therapy may improve vascular outcomes after ischemic stroke, even in cases of LDL-C below the target without pre-stroke lipid-lowering therapy. ANN NEUROL 2024;95:876-885.
引用
- Kim YS, Jeong HG, Chang JY, et al. Effect of Statin Therapy on Cardiovascular Outcome in Stroke Patients with Low Baseline Low-Density Lipoprotein Cholesterol. Ann Neurol. 2024. PMID: 38400785. doi:10.1002/ana.26895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。